Paracetamol ODT - Aptalis

Drug Profile

Paracetamol ODT - Aptalis

Alternative Names: Acetaminophen ODT; AdvaTab Paracetamol ODT; Orally disintegrating paracetamol; Orodispersible paracetamol

Latest Information Update: 09 Mar 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Eurand
  • Developer Aptalis
  • Class Acetanilides; Aminophenols; Antipyretics; Non-opioid analgesics; Small molecules
  • Mechanism of Action Prostaglandin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Fever; Pain

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 09 Mar 2015 No recent reports on development identified - Registered for Pain and Fever in Netherlands and United Kingdom (PO)
  • 09 Mar 2015 No recent reports on development identified - Preregistration for Pain and Fever in Germany, France, Italy and Spain (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top